Latest Global Growth News

EQ Resources delivered a robust Q4 FY2025 with strong tungsten output from its Spanish and Australian operations, bolstered by strategic capital raises and key plant enhancements.

Associate Global Partners Limited reported an 11% increase in funds under management to $1.397 billion for the June quarter 2025, alongside sustained positive operating cash flows and strong fund performance from its WCM strategies.

Acrux Limited has secured a decade-long licensing agreement with Servacure to commercialise its FDA-approved Dapsone 5% Gel in Saudi Arabia, marking a strategic step in its global expansion.

PainChek Limited has secured a A$7.5 million placement to fuel its international expansion, with US FDA clearance for its adult pain assessment app expected imminently. The company reports strong license growth and a 26% revenue increase year-on-year.

ImpediMed Limited reported a record quarter for its SOZO device sales with $6.3 million in contracts, supported by expanded US reimbursement coverage and new funding. Despite stable revenue, the company’s cost-cutting and strategic moves position it well for growth in FY26.

Knosys Limited sustains a robust $9.8 million Annual Recurring Revenue, extends its ANZ Bank contract, and accelerates AI-driven library technology development with promising early market feedback.

EZZ Life Science Holdings marked a pivotal quarter with the launch of its EZZDAY brand in the US, a significant Southeast Asia distribution agreement, and expanded domestic retail presence, driving a 46% jump in customer receipts.

Anagenics Limited reports improved operating cash flow and strong sales from its Bouf Haircare brand, while exploring international expansion and a key licensing deal.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

AGP Investment Management revamps the WCM Quality Global Growth Fund’s distribution policy, moving from annual to quarterly payouts and setting a minimum 5% annual cash yield to enhance investor income predictability.

Pureprofile Limited reported record FY25 results, achieving 19% revenue growth and launching new AI-driven data solutions to fuel future expansion.

Pureprofile has reported record FY25 results, with revenue climbing 19% and EBITDA up 18%, driven by strong international growth and innovative AI platform launches.